Search - tctmd.com

Displaying 141 - 160 of 322

Sort: Relevancy | Date

News Daily News

Mavacamten Successful in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM

Shelley Wood

May 11, 2020

News Daily News

Structural Heart Interventions in the Midst of COVID-19: Today’s Advice, Tomorrow’s Unknowns

Shelley Wood

April 13, 2020

Presentation Controversies and Advances 2019

Echo imaging in HFpEF

Presenter: Jeroen Bax

November 15, 2019

Presentation TCT 2019

Long-term Outcomes of Alcohol Septal Ablation

Presenter: George Hanzel

September 28, 2019

Presentation TCT 2019

Alcohol Septal Ablation Complications and Management

Presenter: Hubert Seggewiss

September 28, 2019

Presentation TCT 2019

The Alcohol Septal Ablation Procedure

Presenter: Valerian Fernandes

September 28, 2019

Presentation TCT 2019

Case Selection for Alcohol Septal Ablation

Presenter: Srihari Naidu

September 28, 2019

Presentation TCT 2019

Clinical Presentation, Pathophysiology, and Natural History

Presenter: Bernard Gersh

September 28, 2019

Presentation TCT 2019

Risk Stratification for Sudden Cardiac Death and ICD Implantation

Presenter: Bernard Gersh

September 28, 2019

Presentation TCT 2019

Medical Treatments for HCM

Presenter: Carey Kimmelstiel

September 28, 2019

Presentation TCT 2019

Imaging in HCM for Diagnosis and Risk Stratification

Presenter: Sherif Nagueh

September 28, 2019

Session I: Innovation and Practice in Structural Heart Intervention - Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy

Presentation TCT 2019

Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy

Presenter: Liwen Liu

September 25, 2019

News Daily News

Preemptive Alcohol Septal Ablation May Help Prevent LVOT Obstruction in TMVR

Yael L. Maxwell

July 11, 2019

News Opinion Fellow Talk

Hemodynamics: The Forgotten Branch of Cardiology

Mesfer Alfadhel, MD

June 28, 2019

Presentation TVT 2019

Gender Differences in the Safety of Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy

Presenter: Abhishek Sharma

June 14, 2019

News Conference News HRS 2019

Cancer Survivors With Heart Failure Respond Well to CRT

Todd Neale

May 14, 2019

News Daily News

In the Wake of Guidelines, Antibiotic Prophylaxis for Infective Endocarditis Declined for Moderate-Risk Patients

L.A. McKeown

May 07, 2019

Presentation ECHO/IMAGING 2019

Hypertrophic Cardiomypathy A Comprehensive Assessment - The Role of Imaging Focus on Echo

Presenter: Kyle W. Klarich

March 23, 2019

News Conference News TCT 2018

ULTIMATE: IVUS Superior to Angiography at Guiding PCI, With Less TVF by 1 Year

Lucy Hicks

September 24, 2018

Presentation TCT 2018

Case #8: Severe Obstructive HCM in a Symptomatic Patient Despite Maximized Medical Therapy and Septal Thickness of 13 mm.

Presenter: Sherif F. Nagueh, Hubert Seggewiss, John S. Douglas Jr, Valerian Fernandes, Vijay Iyer, Srihari S. Naidu, Nish Patel, Alexandre C. Zago

September 24, 2018

Advertisement

Mavacamten Successful in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM

Structural Heart Interventions in the Midst of COVID-19: Today’s Advice, Tomorrow’s Unknowns

Echo imaging in HFpEF

Long-term Outcomes of Alcohol Septal Ablation

Alcohol Septal Ablation Complications and Management

The Alcohol Septal Ablation Procedure

Case Selection for Alcohol Septal Ablation

Clinical Presentation, Pathophysiology, and Natural History

Risk Stratification for Sudden Cardiac Death and ICD Implantation

Medical Treatments for HCM

Imaging in HCM for Diagnosis and Risk Stratification

Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy

Preemptive Alcohol Septal Ablation May Help Prevent LVOT Obstruction in TMVR

Hemodynamics: The Forgotten Branch of Cardiology

Gender Differences in the Safety of Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy

Cancer Survivors With Heart Failure Respond Well to CRT

In the Wake of Guidelines, Antibiotic Prophylaxis for Infective Endocarditis Declined for Moderate-Risk Patients

Hypertrophic Cardiomypathy A Comprehensive Assessment - The Role of Imaging Focus on Echo

ULTIMATE: IVUS Superior to Angiography at Guiding PCI, With Less TVF by 1 Year

Case #8: Severe Obstructive HCM in a Symptomatic Patient Despite Maximized Medical Therapy and Septal Thickness of 13 mm.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content